MedTrace Logo

Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)

NCT04893317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-03-19

No results posted yet for this study

Summary

A prospective, single-arm, multi-center, pre-market, clinical study designed to provide safety and performance data regarding the use of the Adagio Medical VT Cryoablation System in the treatment of ventricular tachycardia.

Conditions

  • Monomorphic Ventricular Tachycardia

Interventions

DEVICE

Ablation in the ventricles with the Adagio Medical VT Cryoablation System

The Adagio Medical VT Cryoablation System is indicated for the treatment of monomorphic ventricular tachycardia by ablation of arrhythmogenic tissue that drives and maintains these arrhythmias

Sponsors & Collaborators

  • Adagio Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-26
Primary Completion
2024-06-30
Completion
2024-09-30

Countries

  • Belgium
  • Canada
  • Czechia
  • France
  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04893317 on ClinicalTrials.gov